149 related articles for article (PubMed ID: 6306946)
1. [Enzymes of glycolipid metabolism and their role in the development of glycolipidoses].
Mkheian EE
Vestn Akad Med Nauk SSSR; 1983; (4):71-7. PubMed ID: 6306946
[No Abstract] [Full Text] [Related]
2. Lysosomal storage diseases.
Glew RH; Basu A; Prence EM; Remaley AT
Lab Invest; 1985 Sep; 53(3):250-69. PubMed ID: 2993742
[No Abstract] [Full Text] [Related]
3. [Inborn error of glycolipid metabolism].
Suzuki Y
Horumon To Rinsho; 1975 Sep; 23(9):885-91. PubMed ID: 166
[No Abstract] [Full Text] [Related]
4. Brain lysosomal enzymes in generalized gangliosidosis and metachromatic leukodystrophy.
Den Tandt WR; Hooghwinkel GJ
Acta Neurol (Napoli); 1980 Feb; 2(1):10-4. PubMed ID: 6156575
[No Abstract] [Full Text] [Related]
5. [Function and relevance of activator proteins for glycolipid degradation].
Sandhoff K
Seikagaku; 1985 Feb; 57(2):87-102. PubMed ID: 3925052
[No Abstract] [Full Text] [Related]
6. Inherited neuropathies related to disorders of lipid metabolism.
Thomas PK
Adv Neurol; 1988; 48():133-44. PubMed ID: 2446477
[No Abstract] [Full Text] [Related]
7. Genetic disorders of lysosomes.
Hirschhorn R; Weissmann G
Prog Med Genet; 1976; 1():49-101. PubMed ID: 180565
[No Abstract] [Full Text] [Related]
8. The biochemistry of sphingolipid storage diseases.
Sandhoff K
Angew Chem Int Ed Engl; 1977 May; 16(5):273-85. PubMed ID: 406814
[No Abstract] [Full Text] [Related]
9. Enzymatic diagnosis of sphingolipidoses.
Suzuki K
Methods Enzymol; 1987; 138():727-62. PubMed ID: 2885713
[No Abstract] [Full Text] [Related]
10. Fibroblast phosphodiesterase deficiency in Niemann-Pick disease.
Fensom AH; Benson PF; Babarik AW; Grant AR; Jacobs L
Biochem Biophys Res Commun; 1977 Feb; 74(3):877-83. PubMed ID: 191016
[No Abstract] [Full Text] [Related]
11. [Procedure for the diagnosis of sphingolipidoses or allied diseases in adult patients with neurological or psychiatric symptoms (author's transl)].
Pilz H; Heipertz R; Seidel D
Nervenarzt; 1979 Dec; 50(12):749-61. PubMed ID: 94938
[No Abstract] [Full Text] [Related]
12. [Phenotypes in heteroglycanoses and sphingolipidoses (author's transl)].
Gehler J
Monatsschr Kinderheilkd; 1981 Nov; 129(11):610-20. PubMed ID: 6798422
[TBL] [Abstract][Full Text] [Related]
13. Human beta-galactosidases: molecular and clinical aspects.
Rittmann LS; O'Brien JS
Isozymes Curr Top Biol Med Res; 1981; 5():77-113. PubMed ID: 6799421
[No Abstract] [Full Text] [Related]
14. Comparative properties of the three groups of splenic beta-glucosidase molecular forms.
Salvayre R; Maret A; Negre A; Douste-Blazy L
Prog Clin Biol Res; 1982; 95():443-52. PubMed ID: 6812080
[No Abstract] [Full Text] [Related]
15. Human brain cerebroside beta-galactosidase: deficiency of transgalactosidic activity in Krabbe's disease.
Carter TP; Beblowski DW; Savage MH; Kanfer JN
J Neurochem; 1980 Jan; 34(1):189-96. PubMed ID: 6778958
[TBL] [Abstract][Full Text] [Related]
16. Heritable catabolic and anabolic disorders of lipid metabolism.
Brady RO
Metabolism; 1977 Mar; 26(3):329-45. PubMed ID: 13262
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic abnormalities in diseases of sphingolipid metabolism.
Brady RO
Clin Chem; 1967 Jul; 13(7):565-77. PubMed ID: 5006481
[No Abstract] [Full Text] [Related]
18. [Recent advances in sphingolipidosis research].
Tamai Y; Kojima H
Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1291-303. PubMed ID: 1972585
[No Abstract] [Full Text] [Related]
19. Disorders of lipid metabolism.
Brady RO
Biochem Soc Symp; 1972; (35):113-27. PubMed ID: 4217183
[No Abstract] [Full Text] [Related]
20. Enzymological approaches to the lipidoses.
Brady RO
Ann Clin Lab Sci; 1977; 7(2):105-12. PubMed ID: 403847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
